Item

In utero xylazine exposure associated with feeding difficulties in infants with Neonatal Opioid Withdrawal Syndrome

Kelsey, Stefanie
Citations
Altmetric:
License
License
Abstract
Xylazine is a significant adulterant in the US illicit drug supply. We reviewed medical and veterinary literature regarding neonatal xylazine exposure and withdrawal and associated symptomology. A retrospective College of Arts and Sciencese review of infants born >35 weeks monitored for neonatal opioid withdrawal syndrome (NOWS) with known xylazine exposure was conducted. 7 out of 52 infants had xylazine exposure. Exposed infants demonstrated differences in NOWS scoring and feeding patterns and required increased feeding support. Animal data indicates developmental risks from prenatal xylazine exposure, but human data is limited. In our College of Arts and Sciencese series, exposure was associated with feeding difficulties.
Description
Date
2025-01-01
Student Status
Medical Students
Journal Title
Journal ISSN
Volume Title
Type of presentation
Poster Presentation
Collections
UVM Student Research Conference
Show all metadata
Research Projects
Organizational Units
Journal Issue
Citation
URI
https://hdl.handle.net/20.500.14849/8880
DOI
Advisor(s)
Julia Litzky
Department
Program/Major
Medical Student
College/School
College of Agriculture and Life Sciences
Organization
item.page.researchcategory
Clinical
Embedded videos